Skip to main content

Table 1 Characteristics of 5,057 patients who were analyzed in the study. The patients initiated ART in 2008 to 2011 at the Immune Suppression Syndrome Clinic in Mbarara, Uganda

From: Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa

Variable  
Age 33 (28–40)a
Sex, Female 63.9 %
Education  
 No education 5.5 %
 Primary 62.1 %
 Secondary or more 32.5 %
Time to clinic  
 ≤1 h 14.8 %
 1-2 h 20.4 %
 2-3 h 21.9 %
 ≥4 h 43.0 %
Marital status  
 Separated 13.2 %
 Divorced 5.7 %
 Widowed 16.8 %
 Single 10.0 %
 Married 54.4 %
Year of ART initiation  
 2008 26.1 %
 2009 19.6 %
 2010 22.0 %
 2011 32.2 %
Opportunistic infections  
 Tuberculosis, history of 5.9 %
 Kaposi’s sarcoma diagnosis 1.6 %
 Cryptococcosis, history of 1.2 %
 Esophagitis 2.2 %
 Oral candidiasis 17.2 %
 Chronic diarrhea 11.3 %
 Weight loss ≥10 % 12.9 %
 HIV-associated dementia 0.57 %
CD4+ T-cell counts (cells/μL)  
  < 100 27.4 %
 100–200 25.9 %
 200–349 36.6 %
  ≥ 350 10.1 %
Hemoglobin (g/dl) 12.3 (11.0–13.7)
Neutrophils (x 103 cells/μL) 1.7 (1.1–2.4)
Eosinophils (x 103 cells/μL) 0.09 (0.04–0.20)
Platelets (x 103 cells/μL) 208 (155–268)
Lymphocytes (x 103 cells/μL)b 1.6 (1.1–2.0)
Initial ART regimens  
 AZT, 3TC, NVP 58.5 %
 AZT, 3TC, EFV 15.1 %
 TDF, 3TC/FTC, EFV 19.4 %
 TDF, 3TC/FTC, NVP 2.9 %
 D4T, 3TC, EFV/NVP 4.1 %
  1. AZT zidovudine, 3TC lamivudine, D4T stavudine, NVP nevirapine, EFV efavirenz, TDF tenofovir
  2. aMedian (Interquartile range) unless otherwise specified
  3. bTotal lymphocyte count (TLC)